Status:
COMPLETED
Pamidronate, Vitamin D, and Calcium for the Bone Disease of Kidney and Heart Transplantation
Lead Sponsor:
Providence Health & Services
Collaborating Sponsors:
The Heart Institute of Spokane
Ochsner Health System
Conditions:
Transplant Bone Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Bone is lost rapidly and fractures occur in 10-20% of patients who receive organ transplants within 2 years. The purpose of this study is to evaluate long-term effects of a pamidronate-vitamin D-calci...
Detailed Description
Pamidronate improves bone mass in numerous disorders of bone. Other bisphosphonates, as well as pamidronate, have been proven to be beneficial in steroid-related bone disorders. Steroid treatment is a...
Eligibility Criteria
Inclusion
- Kidney or heart transplant recipients
Exclusion
- Hyperparathyroidism
Key Trial Info
Start Date :
January 1 1999
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2002
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT00302627
Start Date
January 1 1999
End Date
November 1 2002
Last Update
August 29 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Providence Medical Research Center
Spokane, Washington, United States, 99204